General Biologicals Corporation (TPEX:4117)
4.970
-2.780 (-35.87%)
Mar 10, 2026, 11:50 AM CST
-73.28% (1Y)
| Market Cap | 471.39M |
| Revenue (ttm) | 251.38M |
| Net Income (ttm) | -243.60M |
| Shares Out | 60.83M |
| EPS (ttm) | -4.07 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 5,405,108 |
| Average Volume | 306,649 |
| Open | 7.750 |
| Previous Close | 7.750 |
| Day's Range | 3.500 - 7.820 |
| 52-Week Range | 3.670 - 24.900 |
| Beta | 0.50 |
| RSI | 16.87 |
| Earnings Date | Apr 24, 2026 |